PFAS testing Pace Analytical has recently launched an ultrashort-chain PFAS testing method, signaling a capability to meet rising demand for advanced, regulatory-compliant contamination assessments in environmental services.

Life sciences expansion The company is expanding into life sciences with CDMO/CRO capabilities and FDA-registered laboratories, plus recent asset investments in two life sciences laboratories, creating cross-sell opportunities to pharmaceutical and biopharma clients for testing, development, and stability studies.

Strategic partnerships Partnership with Aspire Biolabs for drug-excipient compatibility and formulation work indicates a channel for jointly pursuing pharmaceutical development programs and expanded testing services for drug products.

Leadership and growth Recent leadership appointments and continued rapid growth, including a new CEO and Director of R&D, point to strategic shifts that can align sales approaches with longer-term partnerships and larger project scopes.

Recognition and capacity Environmental Business Journal award for respirable crystalline silica testing and investments in life sciences laboratories demonstrate validated capabilities and increased capacity to handle larger, diversified client engagements across environmental, industrial, and pharmaceutical sectors.